ZNTL

1.43

0.69% -0.01

Dopo l'orario di chiusura: 1.43

Zentalis Pharmaceuticals Inc (ZNTL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ZNTL Giù? Forum Previsione

Precedente Chiudi:

$1.44

Aprire:

$1.44

Volume 24 ore:

289.00K

Relative Volume:

0.43

Capitalizzazione di mercato:

$103.32M

Reddito:

Utile/perdita netta:

$-292.19M

Rapporto P/E:

-0.315

EPS:

-4.54

Flusso di cassa netto:

$-208.41M

1 W Prestazione:

+6.72%

1M Prestazione:

-16.37%

6M Prestazione:

+14.40%

1 anno Prestazione:

-60.61%

Intervallo 1D:

$1.42

$1.46

Intervallo di 1 settimana:

$1.3314

$1.46

Portata 52W:

$1.01

$4.00

Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile

Nome

Zentalis Pharmaceuticals Inc

Settore

Healthcare (1137)

Industria

Biotechnology (638)

Telefono

(858) 263-4333

Indirizzo

10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY

Dipendente

166

Cinguettio

@ZentalisP

Prossima data di guadagno

2025-03-26

Ultimi documenti SEC

ZNTL's Discussions on Twitter

Confronta ZNTL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ZNTL Zentalis Pharmaceuticals Inc	1.43	104.04M	0	-292.19M	-208.41M	-4.54
VRTX Vertex Pharmaceuticals Inc	433.61	109.65B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	780.19	82.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	451.23	58.81B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	911.98	56.50B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	207.77	43.62B	447.02M	-1.18B	-906.14M	-6.1812

Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-12	Aggiornamento	Wedbush	Underperform → Neutral
2024-06-20	Downgrade	UBS	Buy → Neutral
2024-06-18	Downgrade	Jefferies	Buy → Hold
2024-06-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-06-18	Downgrade	Wedbush	Neutral → Underperform
2024-06-18	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-11-08	Downgrade	Wedbush	Outperform → Neutral
2023-11-07	Downgrade	Leerink Partners	Outperform → Market Perform
2022-07-12	Iniziato	Cowen	Outperform
2022-04-06	Iniziato	Wells Fargo	Overweight
2021-10-07	Ripresa	Jefferies	Buy
2021-09-30	Iniziato	Stifel	Buy
2021-09-29	Iniziato	Oppenheimer	Outperform
2021-05-21	Iniziato	UBS	Buy
2021-01-20	Iniziato	Wedbush	Outperform
2020-09-29	Iniziato	Cantor Fitzgerald	Overweight
2020-08-27	Iniziato	H.C. Wainwright	Buy
2020-04-28	Iniziato	Guggenheim	Buy
2020-04-28	Iniziato	Jefferies	Buy
2020-04-28	Iniziato	Morgan Stanley	Overweight
2020-04-28	Iniziato	SVB Leerink	Outperform

Mostra tutto

Zentalis Pharmaceuticals Inc Borsa (ZNTL) Ultime notizie

Nov 29, 2025

Why Zentalis Pharmaceuticals Inc. stock is favored by top institutions2025 Valuation Update & Weekly High Conviction Ideas - BỘ NỘI VỤ

Nov 29, 2025

Nov 27, 2025

What analysts say about Zentalis Pharmaceuticals Inc stockTake Profit Strategies & Affordable Trading Growth - earlytimes.in

Nov 27, 2025

Is Zentalis Pharmaceuticals Inc. stock trading near support levels2025 Pullback Review & Long-Term Growth Stock Strategies - BỘ NỘI VỤ

Nov 27, 2025

Nov 25, 2025

Zentalis Pharmaceuticals Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo

Nov 25, 2025

Nov 21, 2025

Perhaps timely catching Zentalis Pharmaceuticals Inc (ZNTL) would be a good idea - Setenews

Nov 21, 2025

Connor Clark & Lunn Investment Management Ltd. Decreases Stake in Zentalis Pharmaceuticals, Inc. $ZNTL - Defense World

Nov 21, 2025

Nov 20, 2025

Zentalis Pharmaceuticals (ZNTL) Price Target Decreased by 14.14% to 5.42 - MSN

Nov 20, 2025

Nov 19, 2025

What indicators show strength in Zentalis Pharmaceuticals Inc.Portfolio Growth Summary & Accurate Entry and Exit Point Alerts - newser.com

Nov 19, 2025

Is Zentalis Pharmaceuticals Inc. stock in correction or buying zoneMarket Volume Summary & Free Verified High Yield Trade Plans - newser.com

Nov 19, 2025

Why analysts upgrade Zentalis Pharmaceuticals Inc. stockEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com

Nov 19, 2025

Why Zentalis Pharmaceuticals Inc. stock is in analyst buy zone2025 Analyst Calls & AI Driven Stock Reports - newser.com

Nov 19, 2025

Nov 18, 2025

Is Zentalis Pharmaceuticals Inc. forming a bottoming base2025 Top Decliners & Reliable Price Breakout Alerts - newser.com

Nov 18, 2025

Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL) - Seeking Alpha

Nov 18, 2025

Nov 16, 2025

Multi asset correlation models including Zentalis Pharmaceuticals Inc.Earnings Beat & Weekly High Conviction Trade Ideas - newser.com

Nov 16, 2025

How geopolitical tensions affect Zentalis Pharmaceuticals Inc. stockBuy Signal & Momentum Based Trading Ideas - newser.com

Nov 16, 2025

Wall Street Zen Upgrades Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Hold - Defense World

Nov 16, 2025

Nov 15, 2025

Can Zentalis Pharmaceuticals Inc. stock reach $100 price target2025 Key Highlights & Weekly High Return Stock Opportunities - newser.com

Nov 15, 2025

Nov 14, 2025

FY2025 Earnings Estimate for ZNTL Issued By Leerink Partnrs - Defense World

Nov 14, 2025

What is HC Wainwright’s Estimate for ZNTL FY2025 Earnings? - Defense World

Nov 14, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of “Hold” from Analysts - Defense World

Nov 14, 2025

Wedbush Reiterates “Neutral” Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL) - Defense World

Nov 13, 2025

Morgan Stanley Maintains Zentalis Pharmaceuticals (ZNTL) Equal-Weight Recommendation - MSN

Nov 13, 2025

Nov 12, 2025

Relative strength of Zentalis Pharmaceuticals Inc. in sector analysisPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Nov 12, 2025

ZNTL Stock Update: Morgan Stanley Lowers Price Target by 50% | Z - GuruFocus

Nov 12, 2025

What recovery options are there for Zentalis Pharmaceuticals Inc.2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com

Nov 12, 2025